About
Turn Therapeutics
Our mission is to increase access to effective medicines for high need populations.
Healing Beyond Symptom Relief
Turn Therapeutics was founded by Bradley Burnam during his search for healing and has grown into a company driven to solve biopharma’s most overlooked challenges.
Patients deserve more than temporary relief. We exist to turn the tides in medicine with technologies that heal, not just manage.
PermaFusion® is the engine behind our work, a proprietary mixing technology that fuses liquid and oil. This allows us to create formulas that suspend liquid solubles pharmaceutical ingredients within an oil carrier to safely penetrate skin, nails, and mucous membranes.
The result? Optimal healing without compromise.
our founder, Bradley Burnam, Overcame a 70% fatal infection
He was diagnosed with a deadly, drug-resistant bacterial infection. No available cure stopped its progression. After five years and 20+ procedures, Brad was still battling the same infection. And like so many patients, he found himself not just fighting his condition, but navigating a medical system that offered little more than temporary solutions.
He wanted real healing, not just breaks in a cycle of endless recurrence.
So, he created the one thing that didn’t exist: his own cure.
Out of that necessity to survive came the foundation of Turn Therapeutics: a company with three FDA cleared medical devices, 15+ patents, and a robust drug pipeline.
Now, Turn Therapeutics is focused on advancing its therapies and mission to increase access to safe and effective medicines.
Pioneering Pharma
With Bradley’s relentless pursuit and mission to heal, our versatile delivery platform has driven three FDA cleared medical devices and is now powering our drug candidates for eczema and toenail fungus. The possibilities are endless for how PermaFusion® can be leveraged.









